Invitation to Vimian’s Interim Report for the second quarter of 2021

News
Aug 19 2021

Invitation to Vimian’s Interim Report for the second quarter of 2021

Vimian Group AB will publish its Interim Report for the period of January-June 2021 on Wednesday, 25 August 2021, at 07.45 (CET). In conjunction to this, a telephone and web conference will be organised for investors, analysts and media, on the same day at 09.30 (CET).

CEO, Fredrik Ullman and CFO, Henrik Halvorsen from Vimian will present and comment on the report for the second quarter. The telephone and web conference will be held in English and include a question and answer session.

To attend the telephone conference:
SE: +46850558356
UK: +443333009266
US: +16467224956

To attend the web conference:
Link: https://tv.streamfabriken.com/vimian-group-q2-2021

Related presentation materials will be available at Vimian’s corporate website (https://vimian.com/investors/reports-and-presentations/) ahead of the telephone and web conference.

About Vimian

Vimian is a global, fast-growing group of innovation-driven companies with a shared passion for making a positive impact through improving animal health. Together, we put science, technology and our customers’ needs at the centre of everything we do to deliver effective solutions to veterinary professionals, labs and pet parents around the world. We bring together pioneering and entrepreneurial businesses in animal health, with an aim to create a uniquely diversified proposition of products and services of the highest standard. Our group covers four essential and rapidly evolving areas within animal health: Specialty Pharma, Diagnostics, Veterinary Services and MedTech. Vimian provides individual businesses with access to our networks, expertise, infrastructure and capital to accelerate innovation and growth. We are as passionate about supporting leadership within our existing businesses, as we are about welcoming new partners to the Vimian family – together helping us make an even greater impact by improving animal health. Headquartered in Stockholm, Sweden, Vimian and our family of companies reach over 15,000 customers in +150 markets, employ more than 400 people and have a combined annual turnover of approximately EUR 140 million. For more information, please visit: www.vimian.com.